Levothyroxine is used to treat low thyroid activity and to treat or suppress different types of goiters.

Levothyroxine is a replacement for a hormone normally produced by your thyroid gland to regulate the body's energy and metabolism. Levothyroxine is given when the thyroid does not produce enough of this hormone on its own.

Levothyroxine treats hypothyroidism (low thyroid hormone). It is also used to treat or prevent goiter (enlarged thyroid gland), which can be caused by hormone imbalances, radiation treatment, surgery, or cancer.
At present, United States market is mainly occupied by own brands. The domestic enterprise technology still keeps leading level.

Market Analysis and Insights: Global Levothyroxine Market
In 2019, the global Levothyroxine market size was US$ XX million and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2021-2026.
Global Levothyroxine Scope and Market Size
Levothyroxine market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Levothyroxine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

Segment by Type, the Levothyroxine market is segmented into
Slice in solid
In bottles for injection

Segment by Application, the Levothyroxine market is segmented into
Hospitals
Chemist's shops
Other medical institutions

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape

and Levothyroxine Market Share Analysis
Levothyroxine market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Levothyroxine product introduction, recent developments, Levothyroxine sales by region, type, application and by sales channel.

The major companies include:
Abbott Ltd
Alara Pharm (Sandoz)
Forest (Actavis)
Merck Serono
Piramal Healthcare
Mylan
KING PHARMS R AND D
Jerome Stevens